Limonin alleviates macro- and micro-vascular complications of metabolic syndrome in rats: A comparative study with Azelnidipine (cas 123524-52-7)
-
Add time:07/25/2019 Source:sciencedirect.com
BackgroundHypertension is a serious component of metabolic syndrome (MetS).
We also recommend Trading Suppliers and Manufacturers of Azelnidipine (cas 123524-52-7). Pls Click Website Link as below: cas 123524-52-7 suppliers
Prev:Inhibitory effects of antihypertensive drugs on human cytochrome P450 2J2 activity: Potent inhibition by Azelnidipine (cas 123524-52-7) and manidipine
Next:Inhibitory effects of losartan and Azelnidipine (cas 123524-52-7) on augmentation of blood pressure variability induced by angiotensin II in rats) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Spectroscopic studies on the interaction of Azelnidipine (cas 123524-52-7) with bovine serum albumin08/01/2019
- Enantioselective determination of Azelnidipine (cas 123524-52-7) in human plasma using liquid chromatography–tandem mass spectrometry07/31/2019
- Effect of Azelnidipine (cas 123524-52-7) and amlodipine on single cell mechanics in mouse cardiomyocytes07/30/2019
- Acute effects of intravenous nifedipine or Azelnidipine (cas 123524-52-7) on open-loop baroreflex static characteristics in rats07/29/2019
- Olmesartan with Azelnidipine (cas 123524-52-7) versus with trichlormethiazide on home blood pressure variability in patients with type II diabetes mellitus07/28/2019
- Solid state characterization of Azelnidipine (cas 123524-52-7)–oxalic acid co-crystal and co-amorphous complexes: The effect of different Azelnidipine (cas 123524-52-7) polymorphs07/27/2019
- Inhibitory effects of losartan and Azelnidipine (cas 123524-52-7) on augmentation of blood pressure variability induced by angiotensin II in rats07/26/2019
- Inhibitory effects of antihypertensive drugs on human cytochrome P450 2J2 activity: Potent inhibition by Azelnidipine (cas 123524-52-7) and manidipine07/24/2019
- Improved bioavailability of Azelnidipine (cas 123524-52-7) gastro retentive tablets-optimization and in-vivo assessment07/23/2019